In addition, findings of an individual patient meta-analysis of clinical trials on statin treated patients revealed approximately linear association between elevated baseline and on-statin Lp(a) levels and risk of cardiovascular diseases [18]. This evidence concerns the gene LPA and cardiovascular disorder.